Inspect both the semaglutide vial and bacteriostatic water vial before opening
Short-term safety profile (up to 68 weeks) shows side effects consistent with other incretin medications plus a new signal for dysesthesia
GIP has been shown to decrease food intake while blunting the metabolic adaptive responses that usually occur with calorie restriction resulting in weight reductions, and when combined with GLP-1 receptor agonism, may result in greater effects on markers of metabolic dysregulation such as body weight, glucose and lipids
This means that members with government-sponsored insurance, those on a Kaiser plan, or those without insurance will need to consider one of the following options: (1) pay out of pocket for a GLP-1 medication or (2) if clinically eligible, use a non-GLP-1 medication that is included in the cost of a Weight Watchers Med+ membership
| Concentration | BAC Water | Doses at 1.0mg | Doses at 2.4mg | |---------------|-----------|----------------|----------------| | 5mg/mL | 4.0mL | 20 doses | ~8 doses | | 2.5mg/mL | 8.0mL | 20 doses | ~8 doses | **Note:** At 4mL+ of liquid, ensure you have a large enough syringe (5mL or two separate 3mL draws) to transfer all the BAC water accurately
